Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies. A review
Autologous biologics, defined as platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMC), are cell-based therapy treatment options in regenerative medicine practices, and have been increasingly used in orthopedics, sports medicine, and spinal disorders. These biological products are pr...
Main Authors: | Peter A. Everts, Gerard A. Malanga, Rowan V. Paul, Joshua B. Rothenberg, Natalie Stephens, Kenneth R. Mautner |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Regenerative Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352320419300033 |
Similar Items
-
Modifying Orthobiological PRP Therapies Are Imperative for the Advancement of Treatment Outcomes in Musculoskeletal Pathologies
by: Peter A. Everts, et al.
Published: (2022-11-01) -
Regenerative Medicine for Equine Musculoskeletal Diseases
by: Iris Ribitsch, et al.
Published: (2021-01-01) -
Bioactive Fibrin Scaffolds for Use in Musculoskeletal Regenerative Medicine
by: Sarah Felicio Braga, et al.
Published: (2020-08-01) -
Retrograde autologous priming method reduces plasma free hemoglobin level in aortic surgery
by: Eda Balci, et al.
Published: (2021-01-01) -
Musculoskeletal Development and Skeletal Pathophysiology’s
by: Elizabeth W. Bradley
Published: (2022-08-01)